Related Experiment Video
Updated: Aug 17, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated
Daniel K Tisi1, Xu-Jing Liu, Linda J Wykes
1School of Dietetics and Human Nutrition, McGill University, Montreal, Canada.
Insights
Second-trimester amniotic fluid (AF) insulin-like growth factor binding proteins (IGF BP) 1 and 3 may predict infant birth weight. Higher AF IGF BP1 correlated with lower birth weight, while AF IGF BP3 indicated higher birth weight in large-for-gestational-age infants.
Area of Science:
- Reproductive biology
- Endocrinology
- Fetal development
Background:
- Fetal growth is influenced by amniotic fluid (AF) components, including growth factors.
- Insulin-like growth factor II (IGF II) and its binding proteins (IGF BP) are crucial for fetal development.
- Early pregnancy markers for fetal growth are valuable for clinical assessment.
Purpose of the Study:
- To quantify insulin-like growth factor II (IGF II) and its binding proteins (IGF BP) 1 and 3 in second-trimester amniotic fluid (AF).
- To determine if AF IGF II, IGF BP1, and IGF BP3 concentrations predict infant birth weight and classify fetal growth (small-for-gestational-age [SGA] or large-for-gestational-age [LGA]).
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure AF IGF II, IGF BP1, and IGF BP3.
- Multivariate regression analysis controlled for maternal and infant variables.
- Birth weight was categorized using standardized percentiles for SGA and LGA classification.
Main Results:
- Higher AF IGF BP1 concentrations were associated with lower infant birth weight (partial r² = 0.0062).
- AF IGF BP3 showed a positive association with birth weight in large-for-gestational-age (LGA) and macrosomia subpopulations (partial r² = 0.0283 and 0.0404, respectively).
- IGF II levels were also assessed, though specific associations with birth weight categories were not detailed in the provided text.
Conclusions:
- Second-trimester amniotic fluid IGF BP1 and IGF BP3 may serve as early predictive markers for fetal growth.
- These findings suggest potential for non-invasive monitoring of fetal growth trajectories.
- Further research could elucidate the precise roles of AF IGFs and IGF BPs in regulating fetal size.
Abstract:
The developing fetus begins to swallow amniotic fluid (AF) early in gestation, a process that results in ingestion of numerous growth factors. Our objectives were 2-fold: 1) to assess the concentration and distribution of insulin-like growth factor II (IGF II) and its binding proteins (BP) 1 and 3 in 2nd trimester amniotic fluid using ELISA, and 2) to establish whether concentrations of AF IGF II and its binding proteins IGF BP1 and 3, measured early in pregnancy, were associated with and predictive of infant birth weight. Birth weights were categorized using recently developed birth-weight-for-gestational-age percentiles for fetal growth in which infants < 10% were classified as SGA (small-for-gestational-age) and those > 90% as LGA (large-for-gestational-age). AF samples were collected after routine genetic testing (15.1 +/- 0.04 wk, range 12-20 wk) from 543 mother-infant pairs in Montreal, QC, Canada. Maternal and fetal characteristics were obtained from questionnaires and medical chart review. Multivariate regression analysis that controlled for maternal height, prepregnancy weight, smoking behavior, infant gender, gestational age, parity, as well as amniocentesis week showed that higher AF IGF BP1 was associated with lower birth weight (partial r2 = 0.0062). Regression analyses revealed that AF IGF BP3 was positively associated with birth weight within LGA and macrosomia subpopulations (partial r2 = 0.0283 and 0.0404, respectively). These results show that 2nd trimester AF IGF BP1, BP3, and IGF II may emerge as early indicators of fetal growth.
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Regulation of Angiogenesis and Blood Supply
Diabetes Mellitus: Type 2 and Gestational
Teratogenicity
